CLOCK and cancer: We postulated that this was due to a decrease in the mutation rate in samples that have been whole genome duplicated, which conflicts with the assumption of the model that mutation rate remains constant throughout the lifetime of the cancer genome, and motivated the restriction of mutations used for timing to those classified as “clock-like” (i.e. SBS1 and SBS5).